Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs > OncoSec Medical Inc. (ONCS)

;)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Vulcan4 Member Profile
 
Followed By 73
Posts 2,596
Boards Moderated 0
Alias Born 10/24/13
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/10/2014 9:01:48 AM
OncoSec Medical Announces New Phase II Trial in Head and Neck Cancer Using ImmunoPulse "Business Wire" - 12/9/2014 6:02:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 12/8/2014 5:01:36 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/8/2014 12:26:22 PM
OncoSec Medical Announces First Quarter Results for Fiscal Year End 2015 "Business Wire" - 12/8/2014 6:02:00 AM
OncoSec Reports Positive Top-Line Six-Month Primary Endpoint Data from Phase II Melanoma Trial of ImmunoPulse Monotherapy "Business Wire" - 12/5/2014 11:40:00 AM
OncoSec Medical to Host Corporate Update Conference Call on December 9, 2014 "Business Wire" - 12/5/2014 6:02:00 AM
OncoSec Reports ImmunoPulse May Prolong Survival Based on Analysis of Long-Term Survival Data from Phase I Study in Melanoma "Business Wire" - 12/4/2014 12:00:00 PM
OncoSec Medical Collaborates with PerkinElmer & University of California, Los Angeles to Evaluate Patient-Selection Biomarker... "Business Wire" - 12/2/2014 6:02:00 AM
OncoSec Medical to Present at Two Events in December "Business Wire" - 11/28/2014 6:02:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 11/26/2014 5:06:25 PM
Nature Publication Co-Authored by Robert H. Pierce, Chief Scientific Officer, OncoSec Medical "Business Wire" - 11/26/2014 1:43:00 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 11/26/2014 6:00:24 AM
UC San Francisco and OncoSec Medical Collaborate to Evaluate Investigational Combination of ImmunoPulse and Anti-PD-1 Treatment "Business Wire" - 11/25/2014 3:01:00 AM
OncoSec Medical and the University of Washington Enter Sponsored Research Agreement "Business Wire" - 11/20/2014 6:02:00 AM
OncoSec Medical and Plexxikon Collaborate to Explore Combination Immunotherapy in Preclinical Tumor Studies "Business Wire" - 11/18/2014 6:03:00 AM
OncoSec Medical To Present at 2014 Stifel Healthcare Conference "Business Wire" - 11/13/2014 6:02:00 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 11/12/2014 3:06:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/12/2014 2:50:08 PM
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 11/10/2014 5:26:18 PM
OncoSec Medical Receives VBHRC Funding to Study Novel Gene Therapy Approach in Melanoma "Business Wire" - 11/10/2014 6:02:00 AM
OncoSec Medical to Present New Clinical Data at Melanoma Bridge 2014 "Business Wire" - 11/5/2014 6:02:00 AM
OncoSec Medical To Present at Three Events in November "Business Wire" - 11/3/2014 6:02:00 AM
OncoSec Medical Receives Phase I SBIR Funding for Development of Novel Electroporation Technologies "Business Wire" - 10/27/2014 6:03:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 10/10/2014 5:16:30 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist